Fumaric Acid

Fumaric Acid

SCHEMBL9864131

CCC(O)(CC)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1.O=C(O)C=CC(=O)O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 known ✓ Q01959 12/20 0.52
SLC6A4 known ✓ P31645 11/20 0.52
SLC6A2 known ✓ P23975 4/20 0.52
CHRM2 known ✓ P08172 1/20 0.52
ADRA2A known ✓ P08913 1/20 0.52
ADRA2B known ✓ P18089 1/20 0.52
ADRA2C known ✓ P18825 1/20 0.52
HTR2A known ✓ P28223 1/20 0.52
HTR2B known ✓ P41595 1/20 0.52
KCNH2 known ✓ Q12809 1/20 0.52
OPRK1 P41145 1/20 0.52
CYP3A4 P08684 2/20 0.51
ALOX15 P16050 2/20 0.51
TSHR P16473 2/20 0.51
LMNA P02545 2/20 0.51
ALDH1A1 P00352 1/20 0.51
MAPT P10636 1/20 0.51
MAPK1 P28482 1/20 0.51
TP53 P04637 1/20 0.37
HSD11B1 P28845 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL9864120 1.00 SLC6A3 (0.52) SLC6A3SLC6A4SLC6A2CHRM2ADRA2A
SCHEMBL9864190 0.91 SLC6A3 (0.61) SLC6A3SLC6A4SLC6A2CHRM2ADRA2A
Maleic Acid SCHEMBL9864019 0.89 SLC6A3 (0.54) SLC6A3SLC6A4SLC6A2CHRM2ADRA2A
Fumaric Acid SCHEMBL9864032 0.89 SLC6A3 (0.54) SLC6A3SLC6A4SLC6A2CHRM2ADRA2A
Sibutramine SCHEMBL3707037 0.82 SLC6A3 (0.79) SLC6A3SLC6A4SLC6A2CHRM2ADRA2A
Sibutramine SCHEMBL3715426 0.82 SLC6A3 (0.79) SLC6A3SLC6A4SLC6A2CHRM2ADRA2A
Sibutramine SCHEMBL3705071 0.82 SLC6A3 (0.79) SLC6A3SLC6A4SLC6A2CHRM2ADRA2A
SCHEMBL9864104 0.80 SLC6A3 (0.60) SLC6A3SLC6A4SLC6A2CHRM2ADRA2A
Maleic Acid SCHEMBL9863699 0.80 SLC6A3 (0.54) SLC6A3SLC6A4SLC6A2CHRM2ADRA2A
Fumaric Acid SCHEMBL9863705 0.80 SLC6A3 (0.54) SLC6A3SLC6A4SLC6A2CHRM2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5047432-A Antidepressants THE BOOTS COMPANY PLC (GB) 1991-09-10 US disclosed
EP-0191542-B1 ARYLCYCLOBUTYLALKYL AMINES AND THEIR USE AS ANTIDEPRESSIVE MEDICINES The Boots Company PLC (GB) 1988-06-08 EP disclosed
EP-0191542-A1 Arylcyclobutylalkyl amines and their use as antidepressive medicines The Boots Company PLC (GB) 1986-08-20 EP disclosed